Regulatory
-
An Elite Antitrust and Competition Practice
Hailed by Global Competition Review as “perhaps the best Antitrust and Competition practice for high-tech matters in the world,” Wilson Sonsini’s exceptional Antitrust and Competition practice group represents clients in high-stakes antitrust litigation, mergers, and criminal and civil investigation, in addition to providing valuable counseling on business strategy.
-
Expanded Healthcare and FDA Regulatory Practice
Wilson Sonsini's newly expanded Regulatory practice includes attorneys experienced in helping clients with healthcare, FDA, and consumer product compliance.
-
CFIUS and Export Controls Teams Anchored by Former Government Officials
Wilson Sonsini’s CFIUS and export controls teams include attorneys who have served in the U.S. government on CFIUS and the constituent agencies that enforce national security laws, including the Departments of Commerce, Defense, Homeland Security, and Justice; and the CIA.
-
A Highly Ranked Privacy and Cybersecurity PracticeWilson Sonsini's Privacy and Cybersecurity practice is consistently recognized by well-known ranking authorities such as Law360, Chambers USA, Chambers Global, Chambers Europe, and Legal 500.
Wilson Sonsini is the premier legal advisor to technology, life sciences, and growth enterprises worldwide, as well as the venture firms, private equity firms, and investment banks that finance them. We represent companies from entrepreneurial start-ups to multibillion-dollar global corporations at every stage of development. The firm's attorneys collaborate across a comprehensive range of practice areas and industry groups to help the management, boards of directors, shareholders, and in-house counsel of our clients address their most pressing challenges and pursue their most promising opportunities.
The firm has expanded its regulatory services to address the ongoing need clients have for advice concerning enforcement and oversight agencies, both in the U.S. and certain international markets. Our services include antitrust and competition; privacy and cybersecurity; FDA, healthcare, and consumer products; national security (export trade; CFIUS; and FCPA); and advising on other regulatory issues.
In this area, the firm's clients include companies and other entities that compete in rapidly developing and innovative industries, including the biotech, communications, digital media, energy, financial services, medical devices, software and other sectors.
Overview
Wilson Sonsini is the premier legal advisor to technology, life sciences, and growth enterprises worldwide, as well as the venture firms, private equity firms, and investment banks that finance them. We represent companies from entrepreneurial start-ups to multibillion-dollar global corporations at every stage of development. The firm's attorneys collaborate across a comprehensive range of practice areas and industry groups to help the management, boards of directors, shareholders, and in-house counsel of our clients address their most pressing challenges and pursue their most promising opportunities.
The firm has expanded its regulatory services to address the ongoing need clients have for advice concerning enforcement and oversight agencies, both in the U.S. and certain international markets. Our services include antitrust and competition; privacy and cybersecurity; FDA, healthcare, and consumer products; national security (export trade; CFIUS; and FCPA); and advising on other regulatory issues.
In this area, the firm's clients include companies and other entities that compete in rapidly developing and innovative industries, including the biotech, communications, digital media, energy, financial services, medical devices, software and other sectors.
Alerts
Another Signal on the Antitrust Risks of Pricing Algorithms
On July 29, 2026, the U.S. Court of Appeals for the Third Circuit allowed a class action alleging antitrust violations against companies using a common pricing algorithm to proceed.1 The Third Circuit held that when an “algorithm is in effect collecting non-public commercial information from [competitors] and utilizing the collective pot of data to ‘suggest’ prices to each [competitor],” that “surely raise[s] a plausible inference of collusion under Section 1 of the Sherman Act.”2
Alerts
EU AI Act Enforcement Phase Begins
On August 2, 2026, the European Commission (EC), acting through its European AI Office (EU AI Office), became formally entitled to exercise its powers to investigate and enforce the EU AI Act obligations imposed on providers of general-purpose artificial intelligence (GPAI) models, as well as rules on prohibited AI practices. These powers are significant and include requesting information and documentation, obtaining access to models for evaluation, requiring corrective or risk-mitigation measures, and imposing fines of up to the higher of €15 million or 3 percent of the provider’s worldwide annual turnover.
News Articles
Wilson Sonsini Attorneys Named to Lexology Index: Competition 2026
On July 29, 2026, 10 Wilson Sonsini attorneys were named to the Lexology Index: Competition guide for 2026. The guide ranks leading competition lawyers, state aid specialists, and competition economists who advise and represent clients in internal, regulatory, and criminal investigations.
Alerts
DOJ Revives Targeted Second Requests for Merger Review
On July 23, 2026, the Department of Justice (DOJ) Antitrust Division announced a return to “targeted” Second Request investigations and published a revised model timing agreement. The agreement offers an optional “Expedited Consideration” process potentially allowing investigations to be resolved without a full Second Request production. Under the expedited procedures, parties produce a limited set of documents, data, and information relevant to particular issues and concerns raised by the Antitrust Division. If the targeted production is sufficient to resolve the DOJ’s concerns, the investigation may be terminated without full Second Request compliance. In addition, the targeted production may provide a context for potential settlement negotiations. If concerns remain, the DOJ may require further productions, either of the full Second Request specifications or on modified terms.
Alerts
Back-to-Back Executive Orders Shape the U.S. Quantum Agenda: What Founders and Investors Need to Know
On June 22, 2026, the administration issued two Executive Orders: Executive Order 14413, Ushering in the Next Frontier of Quantum Innovation (Quantum Innovation Executive Order) and Executive Order 14412, Securing the Nation Against Advanced Cryptographic Attacks (Post-Quantum Cryptography Executive Order). Together, the Executive Orders reinforce the federal government’s long-term commitment to quantum information science and technology (QIST) while continuing to frame quantum as both an economic and national security priority. Although they impose relatively few immediate legal obligations on most companies, the Executive Orders provide important signals about where federal investment, procurement, and strategic partnerships are likely to emerge over the coming years.
Newsletters
European Antitrust Bimonthly Bulletin – May/June 2026
The firm is pleased to distribute the European Antitrust Bimonthly Bulletin, which distills the major antitrust developments in Europe over the past two months into concise and actionable takeaways. Companies operating in, or transacting with, Europe should take note of this quarter's developments in merger enforcement, digital markets regulation, and AI-related antitrust scrutiny.
Insights
Alerts
Another Signal on the Antitrust Risks of Pricing Algorithms
On July 29, 2026, the U.S. Court of Appeals for the Third Circuit allowed a class action alleging antitrust violations against companies using a common pricing algorithm to proceed.1 The Third Circuit held that when an “algorithm is in effect collecting non-public commercial information from [competitors] and utilizing the collective pot of data to ‘suggest’ prices to each [competitor],” that “surely raise[s] a plausible inference of collusion under Section 1 of the Sherman Act.”2
Alerts
EU AI Act Enforcement Phase Begins
On August 2, 2026, the European Commission (EC), acting through its European AI Office (EU AI Office), became formally entitled to exercise its powers to investigate and enforce the EU AI Act obligations imposed on providers of general-purpose artificial intelligence (GPAI) models, as well as rules on prohibited AI practices. These powers are significant and include requesting information and documentation, obtaining access to models for evaluation, requiring corrective or risk-mitigation measures, and imposing fines of up to the higher of €15 million or 3 percent of the provider’s worldwide annual turnover.
News Articles
Wilson Sonsini Attorneys Named to Lexology Index: Competition 2026
On July 29, 2026, 10 Wilson Sonsini attorneys were named to the Lexology Index: Competition guide for 2026. The guide ranks leading competition lawyers, state aid specialists, and competition economists who advise and represent clients in internal, regulatory, and criminal investigations.
Alerts
DOJ Revives Targeted Second Requests for Merger Review
On July 23, 2026, the Department of Justice (DOJ) Antitrust Division announced a return to “targeted” Second Request investigations and published a revised model timing agreement. The agreement offers an optional “Expedited Consideration” process potentially allowing investigations to be resolved without a full Second Request production. Under the expedited procedures, parties produce a limited set of documents, data, and information relevant to particular issues and concerns raised by the Antitrust Division. If the targeted production is sufficient to resolve the DOJ’s concerns, the investigation may be terminated without full Second Request compliance. In addition, the targeted production may provide a context for potential settlement negotiations. If concerns remain, the DOJ may require further productions, either of the full Second Request specifications or on modified terms.
Alerts
Back-to-Back Executive Orders Shape the U.S. Quantum Agenda: What Founders and Investors Need to Know
On June 22, 2026, the administration issued two Executive Orders: Executive Order 14413, Ushering in the Next Frontier of Quantum Innovation (Quantum Innovation Executive Order) and Executive Order 14412, Securing the Nation Against Advanced Cryptographic Attacks (Post-Quantum Cryptography Executive Order). Together, the Executive Orders reinforce the federal government’s long-term commitment to quantum information science and technology (QIST) while continuing to frame quantum as both an economic and national security priority. Although they impose relatively few immediate legal obligations on most companies, the Executive Orders provide important signals about where federal investment, procurement, and strategic partnerships are likely to emerge over the coming years.
Newsletters
European Antitrust Bimonthly Bulletin – May/June 2026
The firm is pleased to distribute the European Antitrust Bimonthly Bulletin, which distills the major antitrust developments in Europe over the past two months into concise and actionable takeaways. Companies operating in, or transacting with, Europe should take note of this quarter's developments in merger enforcement, digital markets regulation, and AI-related antitrust scrutiny.
Affiliated Programs
East Coast NextGen VC Forum 2026
LaunchBio’s NextGen VC Forum is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. The forum features expert led sessions that offer practical insights into evaluating, supporting, and scaling science-backed startups. Networking is built into the program to help participants expand their reach and grow their networks. Co-created with Wilson Sonsini, the half-day forum includes a networking lunch, three interactive one-hour sessions, and a closing happy hour.
Affiliated Programs
West Coast NextGen VC Forum
LaunchBio’s NextGen VC Forum is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. The forum features expert led sessions that offer practical insights into evaluating, supporting, and scaling science-backed startups. Networking is built into the program to help participants expand their reach and grow their networks. Co-created with Wilson Sonsini, the half-day forum includes a networking lunch, three interactive one-hour sessions, and a closing happy hour.
Speaking Engagements
AI and Data Privacy
On August 12, Wilson Sonsini partner Maneesha Mithal will participate in the webinar "AI and Data Privacy" alongside Tina Shah Paikeday, General Manager and Responsible AI Senior Advisor at Findem. They will examine individual considerations for managing personal information in an AI-enabled hiring landscape and will discuss key organizational considerations for protecting data and navigating evolving global privacy regulations. To register for the free webinar, please visit the event website.
Speaking Engagements
The FTC After Trump v. Slaughter Conference
Wilson Sonsini partner and former FTC Acting Chairman Maureen Ohlhausen is participating in "The FTC After Trump v. Slaughter," a joint conference of the American Antitrust Institute and the George Washington University Law School's Competition Law Center Competition Law Center.
Events
Affiliated Programs
East Coast NextGen VC Forum 2026
LaunchBio’s NextGen VC Forum is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. The forum features expert led sessions that offer practical insights into evaluating, supporting, and scaling science-backed startups. Networking is built into the program to help participants expand their reach and grow their networks. Co-created with Wilson Sonsini, the half-day forum includes a networking lunch, three interactive one-hour sessions, and a closing happy hour.
Affiliated Programs
West Coast NextGen VC Forum
LaunchBio’s NextGen VC Forum is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. The forum features expert led sessions that offer practical insights into evaluating, supporting, and scaling science-backed startups. Networking is built into the program to help participants expand their reach and grow their networks. Co-created with Wilson Sonsini, the half-day forum includes a networking lunch, three interactive one-hour sessions, and a closing happy hour.
Speaking Engagements
AI and Data Privacy
On August 12, Wilson Sonsini partner Maneesha Mithal will participate in the webinar "AI and Data Privacy" alongside Tina Shah Paikeday, General Manager and Responsible AI Senior Advisor at Findem. They will examine individual considerations for managing personal information in an AI-enabled hiring landscape and will discuss key organizational considerations for protecting data and navigating evolving global privacy regulations. To register for the free webinar, please visit the event website.
Speaking Engagements
The FTC After Trump v. Slaughter Conference
Wilson Sonsini partner and former FTC Acting Chairman Maureen Ohlhausen is participating in "The FTC After Trump v. Slaughter," a joint conference of the American Antitrust Institute and the George Washington University Law School's Competition Law Center Competition Law Center.
Josephine Aiello LeBeau
Partner
Josephine focuses on matters related to compliance and enforcement of U.S. export control and sanctions.
Mark Bass
Partner
Mark Bass is a partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he works with public and private technology companies at all stages of growth. He also represents venture capital funds, private equity firms, and investment banks in financings and public offerings.
Michael S. Casey
Partner
Mike Casey is a dual-qualified, Chambers-ranked (Band 1) partner in Wilson Sonsini Goodrich & Rosati’s London office. His practice focuses on advising clients on sanctions, export controls, anti-corruption, and anti-money laundering issues in investigations, counseling, and compliance matters. In addition, he regularly acts as a specialist in mergers, acquisitions, venture financings, lending arrangements, and other types of corporate transactions. He also frequently advises clients on the UK’s National Security and Investment Act and other foreign direct investment review regimes.
Chambers UK noted that Mike is “a one-stop shop for global sanctions advice” who is “very responsive with his provision of highly commercial advice.” The publication also described Mike as “one of the most experienced practitioners in the market” who “understands and takes into consideration any necessary complexities and understands the importance of commerciality when giving recommendations.”
Mike has led numerous internal and government-initiated investigations involving potential violations of sanctions, export controls, anti-money laundering laws, anti-bribery laws, and fraud laws throughout the world. He has also represented individuals in pending and threatened litigation.
Mike regularly advises clients on a wide range of compliance issues. He works with clients to develop and implement state-of-the-art compliance programs, including corporate policies, training programs, and third-party procedures. Further, Mike assists clients with carrying out due diligence for many types of corporate transactions. He has successfully guided dozens of investors and companies through the NSI Act review process.
Prior to joining Wilson Sonsini, Mike was a partner in the London office of Kirkland & Ellis.
Mike is the author of Sanctions Enforcement and Compliance: A Practitioner’s Guide to OFAC, a treatise published by Bloomberg BNA. Additionally, leading legal publications have published more than 45 of his articles. He has been quoted in numerous publications, including The Wall Street Journal, The New York Times, and Global Investigations Review.
Chambers UK noted that Mike is “a one-stop shop for global sanctions advice” who is “very responsive with his provision of highly commercial advice.” The publication also described Mike as “one of the most experienced practitioners in the market” who “understands and takes into consideration any necessary complexities and understands the importance of commerciality when giving recommendations.”
Mike has led numerous internal and government-initiated investigations involving potential violations of sanctions, export controls, anti-money laundering laws, anti-bribery laws, and fraud laws throughout the world. He has also represented individuals in pending and threatened litigation.
Mike regularly advises clients on a wide range of compliance issues. He works with clients to develop and implement state-of-the-art compliance programs, including corporate policies, training programs, and third-party procedures. Further, Mike assists clients with carrying out due diligence for many types of corporate transactions. He has successfully guided dozens of investors and companies through the NSI Act review process.
Prior to joining Wilson Sonsini, Mike was a partner in the London office of Kirkland & Ellis.
Mike is the author of Sanctions Enforcement and Compliance: A Practitioner’s Guide to OFAC, a treatise published by Bloomberg BNA. Additionally, leading legal publications have published more than 45 of his articles. He has been quoted in numerous publications, including The Wall Street Journal, The New York Times, and Global Investigations Review.
Jocelyn Chow
Partner
Jocelyn Chow is a regulatory and compliance partner in the Hong Kong office of Wilson Sonsini Goodrich & Rosati. With a focus on antitrust, national security, and international trade matters, Jocelyn advises multinational corporations on all aspects of antitrust law, global economic and trade sanctions, export controls, import controls, rules of origin, and foreign investment controls. She works with companies operating across numerous industrial sectors, including defense, bioscience, advanced engineering and technology, aviation, telecommunications and broadcasting, and financial services.
Jodi Daniel
Partner
Jodi Daniel is a nationally recognized leader in digital health law and policy, trusted by health care organizations and technology innovators to navigate the complex and dynamic regulatory landscape of digital health and wellness. With over 30 years of experience in healthcare innovation—including 15 years as a lawyer and senior policymaker at the U.S. Department of Health and Human Services (HHS)—Jodi leverages her extensive experience in digital health and health data to deliver strategic, practical advice to clients engaged in groundbreaking products and services that raise novel legal, policy, and ethical issues.
Mark R. Fitzgerald
Partner
Mark is a veteran attorney who advises technology and life sciences companies on corporate law and transactional matters.
Joshua F. Gruenspecht
Partner
Joshua advises domestic and foreign investors, funds, established companies and startups in regulatory, investigative, and enforcement matters.
Jahna Hartwig
Partner
Jahna Hartwig is a partner at Wilson Sonsini Goodrich & Rosati, where she advises domestic and foreign companies on compliance with international trade laws.
Stephen R. Heifetz
Partner
Stephen advises clients on laws and policies at the intersection of international business and national security. He previously served in the U.S. government on the Committee on Foreign Investment in the U.S.
Andrea Linna
Partner
Andrea Linna is a partner at Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s digital health industry group and its healthcare practice. With more than 15 years dedicated to healthcare law, Andrea exclusively represents digital health and health tech clients, from emerging companies to established industry players and their venture capital investors.
People
Josephine Aiello LeBeau
Partner
Josephine focuses on matters related to compliance and enforcement of U.S. export control and sanctions.
Mark Bass
Partner
Mark Bass is a partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he works with public and private technology companies at all stages of growth. He also represents venture capital funds, private equity firms, and investment banks in financings and public offerings.
Michael S. Casey
Partner
Mike Casey is a dual-qualified, Chambers-ranked (Band 1) partner in Wilson Sonsini Goodrich & Rosati’s London office. His practice focuses on advising clients on sanctions, export controls, anti-corruption, and anti-money laundering issues in investigations, counseling, and compliance matters. In addition, he regularly acts as a specialist in mergers, acquisitions, venture financings, lending arrangements, and other types of corporate transactions. He also frequently advises clients on the UK’s National Security and Investment Act and other foreign direct investment review regimes.
Chambers UK noted that Mike is “a one-stop shop for global sanctions advice” who is “very responsive with his provision of highly commercial advice.” The publication also described Mike as “one of the most experienced practitioners in the market” who “understands and takes into consideration any necessary complexities and understands the importance of commerciality when giving recommendations.”
Mike has led numerous internal and government-initiated investigations involving potential violations of sanctions, export controls, anti-money laundering laws, anti-bribery laws, and fraud laws throughout the world. He has also represented individuals in pending and threatened litigation.
Mike regularly advises clients on a wide range of compliance issues. He works with clients to develop and implement state-of-the-art compliance programs, including corporate policies, training programs, and third-party procedures. Further, Mike assists clients with carrying out due diligence for many types of corporate transactions. He has successfully guided dozens of investors and companies through the NSI Act review process.
Prior to joining Wilson Sonsini, Mike was a partner in the London office of Kirkland & Ellis.
Mike is the author of Sanctions Enforcement and Compliance: A Practitioner’s Guide to OFAC, a treatise published by Bloomberg BNA. Additionally, leading legal publications have published more than 45 of his articles. He has been quoted in numerous publications, including The Wall Street Journal, The New York Times, and Global Investigations Review.
Chambers UK noted that Mike is “a one-stop shop for global sanctions advice” who is “very responsive with his provision of highly commercial advice.” The publication also described Mike as “one of the most experienced practitioners in the market” who “understands and takes into consideration any necessary complexities and understands the importance of commerciality when giving recommendations.”
Mike has led numerous internal and government-initiated investigations involving potential violations of sanctions, export controls, anti-money laundering laws, anti-bribery laws, and fraud laws throughout the world. He has also represented individuals in pending and threatened litigation.
Mike regularly advises clients on a wide range of compliance issues. He works with clients to develop and implement state-of-the-art compliance programs, including corporate policies, training programs, and third-party procedures. Further, Mike assists clients with carrying out due diligence for many types of corporate transactions. He has successfully guided dozens of investors and companies through the NSI Act review process.
Prior to joining Wilson Sonsini, Mike was a partner in the London office of Kirkland & Ellis.
Mike is the author of Sanctions Enforcement and Compliance: A Practitioner’s Guide to OFAC, a treatise published by Bloomberg BNA. Additionally, leading legal publications have published more than 45 of his articles. He has been quoted in numerous publications, including The Wall Street Journal, The New York Times, and Global Investigations Review.
Jocelyn Chow
Partner
Jocelyn Chow is a regulatory and compliance partner in the Hong Kong office of Wilson Sonsini Goodrich & Rosati. With a focus on antitrust, national security, and international trade matters, Jocelyn advises multinational corporations on all aspects of antitrust law, global economic and trade sanctions, export controls, import controls, rules of origin, and foreign investment controls. She works with companies operating across numerous industrial sectors, including defense, bioscience, advanced engineering and technology, aviation, telecommunications and broadcasting, and financial services.
Jodi Daniel
Partner
Jodi Daniel is a nationally recognized leader in digital health law and policy, trusted by health care organizations and technology innovators to navigate the complex and dynamic regulatory landscape of digital health and wellness. With over 30 years of experience in healthcare innovation—including 15 years as a lawyer and senior policymaker at the U.S. Department of Health and Human Services (HHS)—Jodi leverages her extensive experience in digital health and health data to deliver strategic, practical advice to clients engaged in groundbreaking products and services that raise novel legal, policy, and ethical issues.
Mark R. Fitzgerald
Partner
Mark is a veteran attorney who advises technology and life sciences companies on corporate law and transactional matters.
Joshua F. Gruenspecht
Partner
Joshua advises domestic and foreign investors, funds, established companies and startups in regulatory, investigative, and enforcement matters.
Jahna Hartwig
Partner
Jahna Hartwig is a partner at Wilson Sonsini Goodrich & Rosati, where she advises domestic and foreign companies on compliance with international trade laws.
Stephen R. Heifetz
Partner
Stephen advises clients on laws and policies at the intersection of international business and national security. He previously served in the U.S. government on the Committee on Foreign Investment in the U.S.
Andrea Linna
Partner
Andrea Linna is a partner at Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s digital health industry group and its healthcare practice. With more than 15 years dedicated to healthcare law, Andrea exclusively represents digital health and health tech clients, from emerging companies to established industry players and their venture capital investors.
Related Practices
- Advertising, Promotions, and Marketing
- Antitrust and Competition
- Committee on Foreign Investment in the United States (CFIUS)
- Data, Privacy, and Cybersecurity
- Export Control and Sanctions
- FCPA and Anti-Corruption
- Healthcare and FDA Regulatory
- Federal Trade Commission
- Fintech and Financial Services
- National Security and Trade
- Payments
- Strategic Risk and Crisis Management
- Tariffs, Customs, and Import Compliance
Recent Insights
Alerts
Another Signal on the Antitrust Risks of Pricing Algorithms
On July 29, 2026, the U.S. Court of Appeals for the Third Circuit allowed a class action alleging antitrust violations against companies using a common pricing algorithm to proceed.1 The Third Circuit held that when an “algorithm is in effect collecting non-public commercial information from [competitors] and utilizing the collective pot of data to ‘suggest’ prices to each [competitor],” that “surely raise[s] a plausible inference of collusion under Section 1 of the Sherman Act.”2
Learn More
Alerts
EU AI Act Enforcement Phase Begins
On August 2, 2026, the European Commission (EC), acting through its European AI Office (EU AI Office), became formally entitled to exercise its powers to investigate and enforce the EU AI Act obligations imposed on providers of general-purpose artificial intelligence (GPAI) models, as well as rules on prohibited AI practices. These powers are significant and include requesting information and documentation, obtaining access to models for evaluation, requiring corrective or risk-mitigation measures, and imposing fines of up to the higher of €15 million or 3 percent of the provider’s worldwide annual turnover.
Learn More
Recent Events
Affiliated Programs
East Coast NextGen VC Forum 2026
LaunchBio’s NextGen VC Forum is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. The forum features expert led sessions that offer practical insights into evaluating, supporting, and scaling science-backed startups. Networking is built into the program to help participants expand their reach and grow their networks. Co-created with Wilson Sonsini, the half-day forum includes a networking lunch, three interactive one-hour sessions, and a closing happy hour.
Learn More
Affiliated Programs
West Coast NextGen VC Forum
LaunchBio’s NextGen VC Forum is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. The forum features expert led sessions that offer practical insights into evaluating, supporting, and scaling science-backed startups. Networking is built into the program to help participants expand their reach and grow their networks. Co-created with Wilson Sonsini, the half-day forum includes a networking lunch, three interactive one-hour sessions, and a closing happy hour.
Learn More
- Privacy Policy
- Terms of Use
- Accessibility
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.